文献速递瓣膜外科

退行性二尖瓣修复术后早期手术对临床结局的获益

Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair.
PubMed 文献 · Ann Thorac Surg · 2018-06-05

本研究在高容量中心连续纳入2003年1月至2015年12月因重度退行性二尖瓣反流行二尖瓣修复的1,903例患者,按指南相关指征评估手术时机。结果显示8年总体生存率、免于二尖瓣再手术率和免于复发性二尖瓣反流率分别为96%、96%和85%,早期干预组复发性二尖瓣反流发生率显著低于对照组(3% vs 18%,p<0.01)。

要点

  • 8年总体生存率96%、免于二尖瓣再手术率96%、免于复发性二尖瓣反流率85%
  • 早期干预组复发性二尖瓣反流发生率3% vs 18%(p<0.01)
  • 无症状且无指南相关指征者复发率3% vs 31%(p<0.0001)

核心结论

  • 对重度退行性二尖瓣反流,在出现症状、心房颤动和心室功能障碍之前行早期手术干预与良好临床结局相关。
  • 除瓣叶病变复杂性和修复质量外,手术时机也显著影响修复耐久性。
  • 作者认为应推荐早期手术干预以减少复发性二尖瓣反流。

研究设计与样本

  • 单中心连续队列研究,纳入2003年1月至2015年12月因重度退行性二尖瓣反流行二尖瓣修复的1,903例患者。
  • 按指南相关指征(症状、心房颤动、左心室功能障碍、肺动脉高压)评估手术干预时机。
  • 分析临床结局及复发性二尖瓣反流的危险因素。

主要发现

  • 2003年至2015年的13年间,无症状患者比例大幅增加。
  • 8年总体生存率96%、免于二尖瓣再手术率96%、免于复发性二尖瓣反流率85%。
  • 射血分数小于60%、左心室舒张末期内径大于60 mm、孤立性前叶病变、术中轻度残余二尖瓣反流是复发性二尖瓣反流的独立预测因素。
  • 早期干预组复发性二尖瓣反流发生率为3% vs 18%(p<0.01)。
  • 无症状患者亚组分析中,无指南相关指征者复发性二尖瓣反流发生率为3% vs 31%(p<0.0001)。

关键数值与推荐

  • 早期干预组复发性二尖瓣反流发生率3% vs 18%(p<0.01)。
  • 无症状患者中无指南相关指征者复发性二尖瓣反流发生率3% vs 31%(p<0.0001)。
  • 8年总体生存率96%、免于二尖瓣再手术率96%、免于复发性二尖瓣反流率85%。
  • 复发性二尖瓣反流的独立预测因素:射血分数小于60%、左心室舒张末期内径大于60 mm、孤立性前叶病变、术中轻度残余二尖瓣反流。

临床怎么用

  • 作者认为,对重度退行性二尖瓣反流应在症状、心房颤动和心室功能障碍出现之前推荐早期手术干预,以减少复发性二尖瓣反流。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to evaluate the clinical trends of mitral valve repair for degenerative mitral regurgitation and the benefit of early surgical intervention on repair durability in a high-volume center. METHODS: From January 2003 to December 2015, 1,903 consecutive patients with severe degenerative mitral regurgitation underwent mitral valve repair at our institution. The timing of surgical intervention was evaluated by guideline-related indications including symptoms, atrial fibrillation, left ventricular dysfunction, and pulmonary hypertension. Clinical outcomes and risk factors for recurrent mitral regurgitation were analyzed. RESULTS: Over 13 years from 2003 to 2015, trends of preoperative characteristics demonstrated that the proportion of asymptomatic patients substantially increased. The 8-year overall survival, freedom from reoperation for mitral valve, and freedom from recurrent mitral regurgitation were 96%, 96%, and 85%, respectively. Ejection fraction less than 60%, left ventricular end-diastolic dimension greater than 60 mm, isolated anterior leaflet lesion, and intraoperative mild residual mitral regurgitation were independent predictive factors for recurrent mitral regurgitation. The incidence of recurrent mitral regurgitation was significantly lower in the early intervention group (3% versus 18%, p < 0.01). In subgroup analysis of asymptomatic patients, the incidence of recurrent mitral regurgitation was significantly lower in patients without guideline-related indications (3% versus 31%, p < 0.0001). CONCLUSIONS: Early surgical intervention for severe degenerative mitral regurgitation before symptoms, atrial fibrillation, and ventricular dysfunction are associated with excellent clinical outcomes. Besides complexity of leaflet lesion and repair quality, surgical timing also significantly affects repair durability. Early surgical intervention should therefore be recommended to reduce recurrent mitral regurgitation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Zhou T, Li J, Lai H, et al. Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair. Ann Thorac Surg. 2018. PMID: 29883645. doi:10.1016/j.athoracsur.2018.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。